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Treatment of chronic colonization with methicillin-resistant Staphylococcus aureus
(MRSA) and non-MR in cystic ﬁbrosis patients shows a wide variability among CF
units. While some caregivers prescribe continuous treatment with oral antibiotics,
others only treat infectious exacerbations.
Patients and Methods: 39 CF patients were included. The mean age was 24.2
(±7.5) years. All patients were chronically colonized by SA (5% MR), and showed
a poor clinical progress and respiratory function after receiving several conventional
antibiotic cycles to treat infectious exacerbation.
Every patient was prescribed continuous treatment with oral Linezolid: 600mg/12 h
for 15−21 days every 45 days, for a minimum of one year. Serial spirometry,
sputum analysis and blood analysis were determined to rule out toxicity derived
from chronic treatment with Linezolid.
Results: An inﬂection in the pulmonary function drop in FEV1 and FVC was
observed, with a recovery and slowing down of this drop after treatment. In regards
to microbiology, after a treatment period of at least one-year, no resistances to
Linezolid were observed. There was a signiﬁcant raise of fungal colonizations with
ﬁlamentous moulds (Aspergillus). There were no blood changes during the one-year
treatment. Patients described clinical recovery with a signiﬁcant decrease of cough
and expectoration during the treatment with Linezolid.
Conclusion: Treatment with Linezolid cycles is effective and safe in those patients
colonized by SA who present both a clinical and functional torpid progress with
conventional treatments. Linezolid allows the stabilization of the symptoms and
lung function.
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Persistent colonisation of the lung by Pseudomonas aeruginosa is associated with
signiﬁcant increases in morbidity and mortality in cystic ﬁbrosis patients. Chronic
infection with P. aeruginosa results in the bacteria exhibiting adaptation to the
unique CF lung environment. Examples include the development of resistance to
antimicrobial agents, bioﬁlm formation and colony morphology variation. Recently
artiﬁcial sputum media (ASM) has been developed to mimic the nutritional
conditions within the CF lung. We investigated this novel in vitro model system to
monitor the responses of populations of P. aeruginosa to antimicrobial challenge.
P. aeruginosa isolates of the Liverpool Epidemic Strain (LES) were cultured in
ASM for a total of 7 days and then assessed for diversiﬁcation by studying
phenotypic and genotypic attributes in the presence or absence of tobramycin.
After 7 days culture in the ASM there was signiﬁcant evidence of divergence of
isolates with respect to colony morphology and the presence of auxotrophic mutants.
Interestingly there was evidence of increased production of toxic exoproducts such
as pyocyanin in the presence of tobramycin. Increased levels of LES bacteriophages
were also noted with antimicrobial challenge. These results demonstrate that during
growth in ASM P. aeruginosa undergoes phenotypic diversiﬁcation that resembles
population behaviour in CF, and that ASM can be used to model bacterial responses
to antibiotics. These adaptations may help explain the long-term success of the
bacterium within CF patients.
We acknowledge funding from the Dr Hadwen Trust, Novartis Pharmaceuticals UK
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167 Effect of antibiotics on bacteriophage production by a cystic
ﬁbrosis epidemic strain
J.L. Fothergill1,2, E. Mowat2, S. Darch2, M.J. Walshaw3, M.J. Ledson3,
M.A. Brockhurst4, C.A. James2, C. Winstanley1,2. 1Royal Liverpool and
Broadgreen University Hospitals NHS Trust, NIHR Biomedical Research Centre in
Microbial Disease, Liverpool, United Kingdom; 2University of Liverpool, Division
of Medical Microbiology, Liverpool, United Kingdom; 3Liverpool Heart and
Chest Hospital, Liverpool, United Kingdom; 4University of Liverpool, School of
Biological Sciences, Liverpool, United Kingdom
Bacteriophages are viruses that can infect bacteria and integrated phages
(prophages) are common amongst bacterial genomes. Using induction with nor-
ﬂoxacin, we have shown that each of the ﬁve prophages in the genome of the
Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa is able to produce
active progeny phage. The aim of this study was to analyse CF patient sputum
samples for the presence of LES phages, and to determine the effects of CF relevant
antibiotics on phage production by four LES isolates (LESB58, LESB65, LES400
and LES431).
We detected LES phages by plaque and PCR assays directly from patient sputum
samples, and in some patients the level of phages increased during exacerbation. In
Luria broth, antibiotics affecting the cell wall/membrane (meropenem and colistin)
and protein synthesis (tobramycin and azithromycin) showed low levels of induction
of phages in the four LES isolates. Conversely, ciproﬂoxacin, which affects DNA
synthesis, caused a higher level of induction in all of the LES isolates. We found
variation between the LES isolates, with isolate LESB65 consistently producing
more phages than the other isolates. Phage production by LES isolates can also be
detected during growth in an artiﬁcial sputum medium bioﬁlm model.
Phages have been implicated in the adaptability and competitiveness of bacterial
populations. We have shown that phages are readily detectable in CF sputum and
that the choice of antibiotic may inﬂuence the levels of phage production.
We acknowledge funding from the Dr Hadwen Trust, Novartis Pharmaceuticals UK
Ltd (unrestricted educational grant), Wellcome Trust and the NIHR.
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Background: Intravenous antibiotics are crucial to cystic ﬁbrosis (CF) treatment.
A history of adverse reactions undermines treatment by limiting drug choice. Drug
allergy guidelines suggest that careful workup allows some suspect drugs to be used
safely. In collaboration with immunology we critically evaluated suspected adverse
reactions to antibiotics in our CF population.
Method: Serial attendees to our CF Unit were asked about adverse reactions
to antibiotics and the drug allergy documentation checked. Based only on this
information an initial decision was made on whether the relevant drugs should be
used.
Past medical records of the same group were then examined in detail. If
immunologically-mediated reactions were suspected speciﬁc serum allergen IgE
assay, allergen skin prick, intradermal and challenge testing were employed. The
putative allergies were then reclassiﬁed and drugs deemed safe following analysis
were compared to those deemed safe previously.
Results: 20 of 44 patients reported adverse reactions to antibiotics with 46 ‘al-
lergies’ in total. The Table shows the available safe antibiotics based on each
method of acquiring information (p< 0.00001 for a chi-square test of differences
between groups). To date, antibiotics that were previously avoided have been given
uneventfully in four cases.
Approach to antibiotic prescribing
Information
from history and
existing drug
allergy table only
Additional information
from old medical notes and
immunological testing
Avoid completely 33 11
Use (as normal or with limitations,
e.g. at reduced dose, only after a
desensitization regimen)
13 35
Conclusion: A systematic evidence-based approach to evaluating possible drug
allergies is signiﬁcantly improving options for treatment in our CF cohort.
